心力衰竭患者快速检测NT-proBNP的临床价值被引量：1

导出

摘要目的探讨心力衰竭患者快速检测N末端B型脑钠钛前体(NT-proBNP)的临床价值。方法选取心力衰竭患者107例为观察组,选取同期非心血管病患者45例为对照组,采用StausFirstTMNT-proBNP心力衰竭诊断仪快速检测所有患者血浆中NT-proBNP水平,从心功能分级、入院与出院、不良心脏事件、死亡等方面分析快速检测NT-proBNP的临床价值。结果观察组患者NT-proBNP含量((1 053.1±176.4)ng/L)明显高于对照组((71.4±26.9)ng/L),随着心功能分级逐渐加重,观察组患者的NT-proBNP含量呈明显上升趋势。观察组患者入院时NT-proBNP含量明显高于出院时,发生不良心脏事件而再次入院患者明显高于未发生不良心脏事件患者,患者死亡时明显高于入院时。结论心力衰竭患者血浆中NT-proBNP含量明显升高,可影响患者的预后,及时准确对其进行快速检测有助于疾病的诊断和治疗,NT-proBNP快速检测可作为心力衰竭的急诊生化项目。

作者韩朝辉吴飞燕韦衍莉杜梅英

机构地区海南省海口市琼山区医院

出处《现代中西医结合杂志》 CAS 2013年第13期1456-1457,共2页 Modern Journal of Integrated Traditional Chinese and Western Medicine

关键词心力衰竭快速检测 N末端B型脑钠钛前体

分类号 R446.6 [医药卫生—诊断学]

引文网络
相关文献

参考文献6

1Taylor AL,Sabolinski ML,Tam SW,et al. Effect of fixed-dose com- bined isosorbide dinitrate/hydralazine in elderly patients in the afri- can-american heart failure trial [ J ]. Journal of Cardiac Failure, 2012,18(8) :600 -606.
2Hajime S, Hiroshi W, Kenichi S, et al. Congestive heart failure in the elderly: Comparison between reduced ejection fraction and pre- served ejection fraction [ J ]. Journal of Cardiology, 2012,59 ( 2 ) : 215 -219.
3Raquel C, Manuel P, Esther RL, et al. Impact of glomerular filtra- tion rate on urinary BNP and NT - proBNP levels in heart failure [J]. Peptides,2012,33(2) :354 -358.
4Gruson D,Sylvie AA,Thibault L,et al. Measurement of NT- proB- NP with LOCI technology in heart failure patients[ J]. Clinical Bio- chemistry, 2012,45 ( 1/2 ) : 171 - 174.
5熊向晖.血清NT-ProBNP检测对老年人心衰的诊断及预后评估意义[J].当代医学,2011,17(24):70-71. 被引量：6
6于晓丽.NT-proBNP检测在充血性心力衰竭疾病中的诊断价值[J].中国医药指南,2012,10(1):182-183. 被引量：7

二级参考文献12

1张善春,刘兆昶.脑利钠肽在心力衰竭诊治中的研究进展[J].心血管病学进展,2005,26(1):43-46. 被引量：19
2蹇在金.老年人心力衰竭的病因及诊断[J].中华老年医学杂志,2005,24(2):156-158. 被引量：70
3张京梅,李志忠,高玉龙,王苏,刘彤,陶英,卢辛,宋艳东,孙涛,陈玄祖.冠心病患者血浆脑钠肽N末端前体浓度的变化及临床意义[J].北京医学,2007,29(3):129-131. 被引量：15
4Koch M,Trapp R, Kohnle M,et al.B-type natriuretie peptide and severe heart failure at baseline predict overall mortality in incident dialysis patients[J]. Clin Nephrol,2010,73(1):21.
5Del Ry S,Maltinti M. C-type natriuretic peptide and its relationto non-invasive indices of left ventricular function in patients with chronic eart failure[J].Peptides,2008,29(1):79-82.
6Del Ry S,Maltinti M,Piacenti. Cardiac production of C-type natriuretic peptide in heart failure [J].J Cardiovasc Med(Hagerstown), 2006,7(6):397-399.
7Passino C,Ry SD,Severino S,et al.C-type natriuretic peptide expression in patients with chronic heart failure: effects of aerobic training[J].Eur J Cardiovasc Prev Rehabil,2008,15(2): 168-72.
8Eibowim D,Planer D,Rott D,et al.Brain natriuretie peptide levels predict pefioperative events in cardiac patients undergoing noncardiac surgery:a pmspeetive study[J].Cardiology,2008,110(4): 266.
9Bcttencourt P, Ferreira S,Azevedo A,et al.Pliminary data on the potiential usefulness of B-type natriuretie peptide levels in predicting outcomes after hospital discharge in patients with heart failure[J]. Am J Med,2002,113 (3):215.
10Logeart D,Thabut G,Jourdain P, et al .Prediseharge B-type nalriuretie peptide assay for identiing patients at high risk of readmission after deeompensated heart failure[J].J Am Coil Cardiol,2004,43 (4):635.